Seunghwan Shin
Affiliations: | 2014-2020 | Chemical Engineering and Materials Science | University of Minnesota, Twin Cities, Minneapolis, MN |
Google:
"Seunghwan Shin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Park S, Bang SY, Kwag D, et al. (2024) Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone Marrow Transplantation |
| Lee JY, Park SS, Jeon YW, et al. (2023) Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study. Journal of Cancer Research and Clinical Oncology |
| Park SS, Lee JC, Byun JM, et al. (2023) ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma. Npj Precision Oncology. 7: 46 |
| Park S, Kwag D, Kim TY, et al. (2022) A retrospective comparison of salvage intensive chemotherapy venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML). Therapeutic Advances in Hematology. 13: 20406207221081637 |
| Park S, Kim TY, Lee JH, et al. (2021) Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome. Therapeutic Advances in Hematology. 12: 20406207211043748 |
| Cho BS, Min GJ, Park SS, et al. (2021) Low-dose Thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor. American Journal of Hematology |
| Cho BS, Min GJ, Park SS, et al. (2021) Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11. Bone Marrow Transplantation |
| Cho BS, Yahng SA, Min GJ, et al. (2021) Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients. Transplantation and Cellular Therapy |
| Cho BS, Min GJ, Park SS, et al. (2021) Prognostic Impacts of D816V Mutation and Peri-Transplant MRD Monitoring on Acute Myeloid Leukemia with . Cancers. 13 |
| Cho BS, Min GJ, Park S, et al. (2020) Haploidentical versus matched unrelated donor transplantation for acute myeloid leukemia in remission: a prospective comparative study. American Journal of Hematology |